Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
05/1996
05/22/1996CN1122699A Compound balsom pear capsules for curing diabetes and prepn. method thereof
05/21/1996US5519036 Cyclic derivatives pharmaceutical compositions containing these compounds and processes for preparing them
05/21/1996US5519011 Food composite performing function of improving serum lipid
05/21/1996US5519006 Phosphonated arylethanolamine compounds with anti-hyperglycemic and/or anti-obesity activity
05/21/1996US5518999 Method for treating Kaposi's sarcoma and blocking or inhibiting vascular permeability
05/19/1996CA2163158A1 Methods for inhibiting bone loss
05/19/1996CA2163156A1 Methods for lowering serum cholesterol
05/17/1996WO1996014412A2 cDNA ENCODING A BMP TYPE II RECEPTOR
05/17/1996WO1996014339A1 Antibodies
05/17/1996WO1996014331A1 Modified neuropeptide y receptors
05/17/1996WO1996014307A1 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands
05/17/1996WO1996014075A1 Synthetic insulin mimetic substances
05/17/1996CA2180162A1 Synthetic insulin mimetic substances
05/16/1996CA2135813A1 Treatment of obesity
05/15/1996EP0711344A1 Modified alpha-lactalbumin
05/15/1996EP0711287A1 Benzo-fused lactams promote release of growth hormone
05/15/1996EP0711284A1 2-benzoheterocyclyloxy or thiopropanolamine derivatives with adreno receptor agonist activity
05/15/1996EP0711282A1 Compounds as pde iv and tnf inhibitors
05/15/1996EP0711272A1 Indane and tetrahydronaphthalene derivatives as calcium channel antagonists
05/15/1996EP0711271A1 Aminoindanes and related compounds useful as calcium-channel antagonists
05/15/1996EP0711141A1 Cosmetic or pharmaceutical and particularly dermatological composition containing an extract of tephrosia, particularly tephrosia purpurea
05/15/1996EP0465565B1 Treatment of aids dementia, myelopathy and blindness
05/15/1996EP0456835B1 Quinazoline-3-alkanoic acid derivative, salt thereof, and production thereof
05/15/1996DE4439947A1 2,2-Dichloralkancarbonsäuren, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel 2,2-Dichloralkancarbonsäuren, processes for their preparation and pharmaceutical compositions containing them
05/15/1996CN1122337A Stable crystalline (6S)-and (6R)-tetrahydrofolic acid
05/15/1996CN1122331A Benzene, pyridine and pyrimidine derivative
05/15/1996CN1122248A Insulin analog formulations
05/15/1996CN1122224A Pharmaceutical with anti-high-blood-sugar function
05/14/1996US5516925 Amino acid chelates having improved palatability
05/14/1996US5516684 Biologically pure culture of Lactobacillus acidophilus FERM-P-14204 or FERM-P-14205
05/14/1996US5516675 Separation of lactoperoxidase, secretory component and lactoferrin from milk or whey with a cation exchange resin
05/14/1996US5516653 Genetic engineering
05/14/1996US5516533 Fluidized intestinal submucosa and its use as an injectable tissue graft
05/09/1996WO1996013585A1 A novel family of protease inhibitors, and other biologic active substances
05/09/1996WO1996013499A1 Apolipoprotein-b synthesis inhibitors
05/09/1996WO1996013484A1 Azetidinone derivatives for the treatment of atherosclerosis
05/09/1996WO1996013265A1 4-heterocyclic piperidines promote release of growth hormone
05/09/1996WO1996013264A1 Oral hypoglycemic agents
05/09/1996CA2203827A1 Novel family of protease inhibitors, and other biologic active substances
05/09/1996CA2203277A1 Oral hypoglycemic agents
05/09/1996CA2202784A1 4-heterocyclic piperidines promote release of growth hormone
05/08/1996EP0710674A2 Glucan having cyclic structure and method for producing the same
05/08/1996EP0710278A1 Cell matrix stimulated cell attachment and hemidesmosome assembly
05/08/1996EP0710241A1 Novel silylated benzylamine derivatives, salts thereof, methods of manufacture and pharmaceutical compositions containing them
05/08/1996EP0710239A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
05/08/1996CN1122133A Novel bisoxadiazolidine derivative
05/08/1996CN1121828A Medicinal health beverage formulation
05/07/1996US5514706 Diabetes
05/07/1996US5514374 Cosmetic or pharmaceutical composition containing a black horehound extract
05/07/1996CA2075551C Treatment of periodontitis
05/07/1996CA2000283C Proteinaceous composition
05/02/1996WO1996012742A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases
05/02/1996WO1996012741A1 Binding agents to cd23
05/02/1996WO1996012719A1 Quinoline derivative
05/02/1996WO1996012697A2 Calcium receptor-active compounds
05/02/1996WO1996012490A1 Methods of inhibiting conditions associated with neuropeptide y
05/02/1996CA2203364A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases
05/02/1996CA2203363A1 Binding agents to cd23
05/02/1996CA2201113A1 Quinoline derivatives
05/02/1996CA2200990A1 Methods of inhibiting conditions associated with neuropeptide y
05/01/1996EP0709386A1 Fused benzazepine derivative and pharmaceutical composition containing the same
05/01/1996EP0708778A1 Imidazo[1,2-a]pyrazin-4-one derivatives for use as ampa and nmda receptor antagonists
05/01/1996EP0708774A1 Imidazo [1,2-a]pyrazine-4-one, preparation thereof and drugs containing same
05/01/1996EP0708768A1 Tri-substituted imidazoles having multiple therapeutic properties
05/01/1996EP0708766A1 Use of coumarins as pla 2-inhibitors, new coumarins, process for preparing the same and medicaments
05/01/1996EP0708764A1 Enanthioselective preparation of thiazole derivatives
05/01/1996EP0708755A1 Novel vitamin d analogues
05/01/1996EP0708656A1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
05/01/1996EP0708655A1 Methods of using insulin-like growth factor binding proteins
05/01/1996EP0708648A1 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid
05/01/1996EP0457883B1 New bicyclic amino-substituted compounds
05/01/1996CN1121692A Composition containing cholestyramine and method of producing the same
05/01/1996CN1121690A Use of thiazolidinediones for the treatment of atherosclerosis and eating disorders
05/01/1996CN1121689A Use of indole derivatives as 5HT1 antagonists
05/01/1996CN1031713C Process for preparing 9-purinyl phosphonic acid derivatives
05/01/1996CN1031705C Process for preparing 24-homo-vitamin-D-derivatives
04/1996
04/30/1996US5512595 Substituted phenoxyisobutyric acids and esters
04/30/1996US5512591 Treatments for diseases characterized by neovascularization
04/30/1996US5512583 Methods of decreasing serum calcium levels
04/30/1996US5512576 2-substituted 1,2,5,-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
04/30/1996US5512570 Treatment of emesis with morpholine tachykinin receptor antagonists
04/30/1996US5512558 Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
04/30/1996US5512549 Antidiabetic agents
04/30/1996US5512459 Transpeptization by contacting peptide and addition unit with thrombin to cleave leaving unit from core at enzyme cleavage site
04/30/1996US5512303 Injectable pharmaceutical composition
04/30/1996CA1338302C Therapeutic octapeptide somatostatin analogs
04/30/1996CA1338287C Hetrazepines and processes for preparing them
04/25/1996WO1996011953A1 N-terminally chemically modified protein compositions and methods
04/25/1996WO1996011950A1 Method of treating diabetes mellitus using kgf
04/25/1996WO1996011949A2 Analogs of keratinocyte growth factor
04/25/1996WO1996011940A1 Acyl amino acetamide derivatives with agonist activity for cck-a receptors
04/25/1996WO1996011701A1 Enteric coated compositions of 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity
04/25/1996WO1996011691A1 Use of 1,5-benzodiazepine derivatives for the control of gastric emptying in patients with non-insulin dependent diabetes mellitus
04/25/1996WO1996011685A2 Use of indole derivatives for the treatment of various diseases
04/25/1996CA2472085A1 N-terminally chemically modified protein compositions and methods
04/24/1996EP0708179A2 Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
04/24/1996EP0708099A1 Tricyclic amide compounds, process for their preparation and pharmaceutical compositions containing them
04/24/1996EP0708098A1 Oxime derivatives, their preparation and their therapeutic use
04/24/1996EP0707596A1 Conjugation-stabilized polypeptide compositions
04/24/1996EP0707491A1 Use of human growth hormone for preoperative administration
1 ... 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 ... 1298